{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-079596","form_type":"8-K","ticker":"DERM","cik":"0001867066","company_name":"Journey Medical Corp","filed_at":"2024-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.018424+00:00","generated_at":"2026-05-31T21:26:07.904929+00:00","sec_items":["1.01","2.03","5.02"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Journey Medical increases credit facility to $25M, appoints new director Michael C. Pearce","bullets":["Credit facility increased from $20M to $25M; additional $5M available upon FDA approval of DFD-29 by June 30, 2025.","Term loan matures Dec 27, 2027; interest = 3-month SOFR (floor 5%) + 7.75%.","Principal repayment starts Feb 2026 at 7.5% quarterly; delayed if trailing revenue >$70M as of Dec 2025.","Appointed Michael C. Pearce to Board (size now six); receives 30,000 RSUs, $50K annual RSU grant, $50K cash retainer.","Adopted non-qualified deferred compensation plan for non-employee directors and select executives."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-079596","json":"https://secwatch.observer/filing/0001104659-24-079596.json","markdown":"https://secwatch.observer/filing/0001104659-24-079596.md","text":"https://secwatch.observer/filing/0001104659-24-079596.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1867066/000110465924079596/0001104659-24-079596-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1867066/000110465924079596/tm2419378d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T21:26:07.904929+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"23fc75c2e0","claim":"Michael C. Pearce was appointed as Director at Journey Medical Corp.","evidence_excerpt":"appointed Michael C. Pearce, age 62, to serve on the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465924079596/0001104659-24-079596-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}